JOHN A SCARLETT Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JOHN A SCARLETT.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOHN A SCARLETT. JOHN A SCARLETT is Chairman, President and CEO in GERON CORP ($GERN) and President and CEO in GERON CORP ($GERN) and President, CEO and Chairman in GERON CORP ($GERN) and Director in CHIASMA, INC ($CHMA) and in CytomX Therapeutics, Inc. ($CTMX) and Director in CytomX Therapeutics, Inc. ($CTMX).
Latest Insider Trading Transactions of JOHN A SCARLETT
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CHMA, CTMX, GERN
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 04 2021 | GERN | GERON CORP | SCARLETT JOHN A | Chairman, President ... | Option Exercise | A | 2.06 | 600,000 | 1,233,000 | 600,000 | |
Jun 18 2020 | CTMX | CytomX Therapeutic ... | SCARLETT JOHN A | Director | Option Exercise | A | 8.35 | 20,000 | 167,000 | 20,000 | |
Jun 12 2020 | CHMA | CHIASMA, INC | SCARLETT JOHN A | Director | Option Exercise | A | 5.81 | 13,000 | 75,530 | 13,000 | |
Jun 12 2020 | CHMA | CHIASMA, INC | SCARLETT JOHN A | Director | Option Exercise | A | 5.81 | 13,000 | 75,530 | 13,000 | |
Feb 14 2020 | GERN | GERON CORP | SCARLETT JOHN A | Chairman, President ... | Option Exercise | A | 1.30 | 582,750 | 754,661 | 582,750 | |
Jun 21 2019 | CTMX | CytomX Therapeutic ... | SCARLETT JOHN A | Director | Option Exercise | A | 11.31 | 14,000 | 158,340 | 14,000 | |
Jun 17 2019 | CHMA | CHIASMA, INC | SCARLETT JOHN A | Director | Option Exercise | A | 7.98 | 13,000 | 103,740 | 13,000 | |
Feb 01 2019 | GERN | GERON CORP | SCARLETT JOHN A | President, CEO and ... | Option Exercise | A | 1.03 | 1,050,000 | 1,081,500 | 1,050,000 | |
Jun 15 2018 | CTMX | CytomX Therapeutic ... | SCARLETT JOHN A | Director | Option Exercise | A | 25.25 | 14,000 | 353,500 | 14,000 | |
Jun 11 2018 | CHMA | CHIASMA, INC | SCARLETT JOHN A | Director | Option Exercise | A | 1.45 | 13,000 | 18,850 | 13,000 | |
Feb 02 2018 | GERN | GERON CORP | SCARLETT JOHN A | President and CEO | Option Exercise | A | 2.45 | 1,050,000 | 2,572,500 | 1,050,000 | |
Jun 22 2017 | CTMX | CytomX Therapeutic ... | SCARLETT JOHN A | Director | Option Exercise | A | 13.78 | 14,000 | 192,920 | 14,000 | |
Jun 19 2017 | CHMA | CHIASMA, INC | SCARLETT JOHN A | Director | Option Exercise | A | 1.35 | 13,000 | 17,550 | 13,000 | |
Feb 10 2017 | GERN | GERON CORP | SCARLETT JOHN A | President and CEO | Option Exercise | A | 2.15 | 1,050,000 | 2,257,500 | 1,050,000 | |
Jun 14 2016 | CTMX | CytomX Therapeutic ... | SCARLETT JOHN A | Option Exercise | A | 10.17 | 28,000 | 284,760 | 28,000 | ||
Jun 13 2016 | CHMA | CHIASMA, INC | SCARLETT JOHN A | Director | Option Exercise | A | 3.14 | 10,000 | 31,400 | 10,000 | |
Feb 12 2016 | GERN | GERON CORP | SCARLETT JOHN A | President and CEO | Option Exercise | A | 2.54 | 600,000 | 1,524,000 | 600,000 | |
Mar 16 2015 | GERN | GERON CORP | SCARLETT JOHN A | President and CEO | Option Exercise | A | 4.34 | 600,000 | 2,604,000 | 600,000 |
Page: 1